Torrey Growth & Income Advisors

Position in SPRO — Spero Therapeutics, Inc.

CIK 2087822 DEL MAR, CA

Position in SPRO

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$39,838

+$170 QoQ

Shares Held

17,025

0.0% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Torrey Growth & Income Advisors holds $6,964,754 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,710	$2,339,598
2	VCEL	Vericel Corp	38,308	$1,704,322
3	NTLA	Intellia Therapeutics, Inc.	70,669	$1,195,719
4	IBRX	ImmunityBio, Inc.	118,860	$1,040,619
5	CADL	Candel Therapeutics, Inc.	66,456	$684,496

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,838	17,025	0.0%	Shares	Sole	2026-04-21
2025-12-31	$39,668	17,025	+7.9%	Shares	Sole	2026-02-17
2025-09-30	$29,657	15,775	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.